If you have any problems in viewing this Newsletter, please click here
03.03.2016
Premium Source for Kinase Research

Defective signalling by protein kinases accounts for more than 400 human diseases. Mutations in kinases can also confer drug resistance, which poses an increasing challenge to development of effective therapeutics. Targeting protein kinases by small molecule inhibitors or neutralizing antibodies has been extremely beneficial in the treatment of various human diseases. More than 10 drugs targeting protein kinases have been approved while another 60 candidates are in clinical trials.

SignalChem offers the most extensive range of Kinases, medically relevant human recombinant Active Kinase Mutants, Kinase Proteins and Antibodies against Kinases, specially to support functional studies and development for the next generation of kinase drugs.

 
Kinases
Active Kinases
Active Kinase Mutants
Unactive Kinases
Kinase Proteins
Fructose Kinases

siRNA Sets
Browse for Kinase siRNA Sets
 
Antibodies against Kinases
Isoform-specific Antibodies against Kinases
Browse Primary Antibodies against Kinases
Browse Phospho-Specific Antibodies against Kinases

Kinase Activators / Inhibitors
Kinase Activators
Kinase Inhibitors
 

Lucerna-Chem respects the web and the privacy of those who use it. We do not rent or sell our mailing list to anyone.
This e-Mail is Virus checked!

If you'd rather not receive Emails about product updates or Newsletters, click HERE.